AbbVie (ABBV) Shares Issued (2013 - 2025)
AbbVie (ABBV) reported Shares Issued of $48.0 million for Q4 2025, up 380.0% year-over-year from $10.0 million in Q4 2024, and down 23.81% quarter-over-quarter from $63.0 million in Q3 2025.
AbbVie (ABBV) Shares Issued (2013 - 2025) Analysis & Trends
AbbVie (ABBV) has 13 years of Shares Issued data on file, last reported at $48.0 million in Q4 2025.
- Shares Issued for Q4 2025 came in at $48.0 million, up 380.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $172.0 million (down 19.63% YoY), and the FY2025 annual result was $172.0 million, down 19.63% from the prior year.
- Shares Issued retreated to $48.0 million in Q4 2025 per ABBV's latest filing, from $63.0 million in the prior quarter.
- Over five years, Shares Issued peaked at $128.0 million in Q1 2022 and troughed at $5.0 million in Q2 2025.
- A 5-year average of $53.6 million and a median of $54.5 million in 2022 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2021 and 2024: Shares Issued jumped 491.67% in 2021, then sank 79.17% in 2024.
- A 5-year view of Shares Issued shows it stood at $75.0 million in 2021, then declined by 29.33% to $53.0 million in 2022, then sank by 41.51% to $31.0 million in 2023, then slumped by 67.74% to $10.0 million in 2024, then surged by 380.0% to $48.0 million in 2025.
- Business Quant data shows ABBV's Shares Issued at $48.0 million in Q4 2025, $63.0 million in Q3 2025, and $5.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 10.79 Mn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 1.17 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | - |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 157.00 Mn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 166.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | - |
| 10 | Novartis Ag | 109.78 Bn | 109.09 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48.00 Mn |
| Dec 31, 2025 | 48.00 Mn |
| Sep 30, 2025 | 63.00 Mn |
| Sep 30, 2025 | 63.00 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 56.00 Mn |
| Mar 31, 2025 | 56.00 Mn |
| Dec 31, 2024 | 10.00 Mn |
| Dec 31, 2024 | 10.00 Mn |
| Sep 30, 2024 | 67.00 Mn |
| Sep 30, 2024 | 67.00 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Mar 31, 2024 | 127.00 Mn |
| Mar 31, 2024 | 127.00 Mn |
| Dec 31, 2023 | 31.00 Mn |
| Dec 31, 2023 | 31.00 Mn |
| Sep 30, 2023 | 36.00 Mn |
| Sep 30, 2023 | 36.00 Mn |